Working… Menu
Trial record 1 of 36 for:    retina associates of kentucky
Previous Study | Return to List | Next Study

Intravitreal Ranibizumab for the Treatment of Choroidal Neovascularization in Ocular Histoplasmosis Syndrome (IVL for OHS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00955630
Recruitment Status : Unknown
Verified August 2009 by Retina Associates of Kentucky.
Recruitment status was:  Recruiting
First Posted : August 10, 2009
Last Update Posted : August 10, 2009
Genentech, Inc.
Information provided by:
Retina Associates of Kentucky

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Unknown
Estimated Primary Completion Date : August 2010
Study Completion Date : No date given
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 May 31, 2013
July 31, 2013
2 August 7, 2013
October 11, 2013
3 June 13, 2014
(Canceled - Date Unknown)
September 23, 2014
September 23, 2014
4 September 23, 2014
September 24, 2014
5 June 9, 2015
June 11, 2015